未登录

S

Sui Peng

sun yat -sen university

H指数:12

被引数:582

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AI-Assisted Glucocorticoid Treatment Response Prediction of Active Ulcerative Active Patients

AI辅助糖皮质激素治疗反应预测活动性溃疡性结肠炎患者

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2025-04-300

PRE

Single-Cell Transcriptomic Analysis Reveals an Aggressive Basal-Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2025-02-010

PRE

Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-11-2325

OAAI

Neoadjuvant tislelizumab for resectable recurrent hepatocellular carcinoma: A non-randomized control, phase II trial (TALENT)

ANNALS OF ONCOLOGY

IF65.4

2022-09-016

OAAI

Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy

IF15.8

2022-07-0133

OA

Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population

IF3.4

2022-06-282

OAAI

Innovative Synoptic Reporting With Seven-Point Sampling Protocol to Improve Detection Rate of Microvascular Invasion in Hepatocellular Carcinoma

采用七点采样方案的创新天气报告可提高肝细胞癌微血管侵犯的检出率

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-046

OAAI

Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling Protocol

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2021-03-2228

PRE

A Pre-Operative Prognostic Score for Patients With Advanced Hepatocellular Carcinoma Who Underwent Resection

FRONTIERS IN ONCOLOGY

IF3.3

2021-02-264

OAAI

Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2020-05-187

PREAI

Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2019-11-0652

OAAI

Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma

IF15.2

2019-07-0155

PREAI

Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma

多灶性肝细胞癌的基因组和转录异质性

ANNALS OF ONCOLOGY

IF65.4

2019-06-0192

OAAI

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model

IF3.4

2018-11-127

OAAI

Salvage Resection for Recurrent or Metastatic Hepatocellular Carcinoma After Percutaneous Ablation Therapy: Old Therapy Served as New Strategy

GASTROENTEROLOGY

IF25.1

2016-04-010

PREAI